Low-protein diet supplemented with ketoacids reduces the severity of renal disease in 5/6 nephrectomized rats: A role for KLF15

Kidney International

Volumn 79, Issue 9, 2011, Pages 987-996

  Gao, Xiang ^a   Huang, Lianghu ^b,c   Grosjean, Fabrizio ^c   Esposito, Vittoria ^c   Wu, Jianxiang ^a   Fu, Lili ^a   Hu, Huimin ^a   Tan, Jiangming ^b   He, Cijian ^c   Gray, Susan ^d   Jain, Mukesh K ^e   Zheng, Feng ^b,c   Mei, Changlin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Department of Anesthesiology   (China)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

5 6 nephrectomy; ketoacids; KLF15; protein restriction

Indexed keywords

ALBUMIN; COLLAGEN TYPE 4; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 15; OXOACID; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; GENE OVEREXPRESSION; GENE REPRESSION; GLOMERULOSCLEROSIS; GROWTH RETARDATION; HUMAN; HUMAN CELL; KIDNEY INJURY; KNOCKOUT MOUSE; MALE; MESANGIUM CELL; MOUSE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RESTRICTION; PROTEINURIA; RAT; RENAL PROTECTION; UREA NITROGEN BLOOD LEVEL;

EID: 79954575325     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.539     Document Type: Article

References (37)

1. Levey AS, Greene T, Beck GJ et al. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol 1999; 10: 2426-2439. (Pubitemid 29501478)
2. Fouque D, Wang P, Laville M et al. Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. Nephrol Dial Transplant 2000; 15: 1986-1992.
3. Nankivell BJ, Tay YC, Boadle RA et al. Dietary protein alters tubular iron accumulation after partial nephrectomy. Kidney Int 1994; 45: 1006-1013. (Pubitemid 24234717)
4. Bergesio F, Monzani G, Guasparini A et al. Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment. Clin Nephrol 2005; 64: 103-112. (Pubitemid 41079006)
5. Bernhard J, Beaufrère B, Laville M et al. Adaptive response to a lowprotein diet in predialysis chronic renal failure patients. J Am Soc Nephrol 2001; 12: 1249-1254. (Pubitemid 32472639)
6. Mitch WE. Dietary therapy in uremia: the impact on nutrition and progressive renal failure. Kidney Int Suppl 2000; 75: S38-S43. (Pubitemid 30205438)
7. Mitch WE. Metabolism and metabolic effects of ketoacids. Am J Clin Nutr 1980; 33: 1642-1648. (Pubitemid 10010765)
8. Feng JX, Hou FF, Liang M et al. Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model. Kidney Int 2007; 71: 901-911. (Pubitemid 46663795)
9. Cho KH, Kim HJ, Rodriguez-Iturbe B et al. Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. Am J Physiol Renal Physiol 2009; 297: F106-F113.
10. Rodŕguez-Iturbe B, Pons H, Herrera-Acosta J et al. The role of immunocompetent cells in non-immune renal diseases. Kidney Int 2001; 59: 1626-1640.
11. Turner J, Crossley M. Kruppel-like transcription factors: more than just a pretty finger. Trends Biochem 1999; 24: 236-240.
12. Dang DT, Pevsner J, Yang VW. The biology of the mammalian Kruppel-like family of transcription factors. Int J Biochem Cell Biol 2000; 32: 1103-1121. (Pubitemid 32008299)
13. Uchida S, Tanaka Y, Ito H et al. Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney enriched Kruppel-like factor, a novel zinc finger repressor. Mol Cell Biol 2000; 20: 7319-7331.
14. Mori T, Sakaue H, Iguchi H et al. Role of Krü ppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J Biol Chem 2005; 1: 12867-12875.
15. Fisch S, Gray S, Heymans S et al. Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 2007; 24: 7074-7079. (Pubitemid 47186011)
16. Gray S, Wang B, Orihuela Y et al. Regulation of gluconeogenesis by Krü ppel-like factor 15. Cell Metab 2007; 5: 305-312. (Pubitemid 46477856)
17. Haldar SM, Lu Y, Jeyaraj D et al. Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation. Sci Transl Med 2010; 2: 26-26.
18. Wang B, Haldar SM, Lu Y et al. The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. J Mol Cell Cardiol 2008; 45: 193-197.
19. Stenvinkel P, Heimbü rger O, Tuck CH et al. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure. Kidney Int 1998; 53: 1336-1342. (Pubitemid 28316895)
20. Masud T, Young VR, Chapman T et al. Adaptive responses to very low protein diets: the first comparison of ketoacids to essential amino acids. Kidney Int 1994; 45: 1182-1192.
21. Meireles CL, Price SR, Pereira AM et al. Nutrition and chronic renal failure in rats: what is an optimal dietary protein? J Am Soc Nephrol 1999; 10: 2367-2373. (Pubitemid 29501470)
22. Bergesio F, Monzani G, Guasparini A et al. Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment. Clin Nephrol 2005; 64: 103-112. (Pubitemid 41079006)
23. Rydzewski A. Low protein diet causes a decrease in serum concentrations of leptin and tumour necrosis factor-alpha in patients with conservatively treated chronic renal failure. Nephrology (Carlton) 2004; 9: 319-324. (Pubitemid 39576936)
24. Schiller B, Moran J. Focal glomerulosclerosis in the remnant kidney model-an inflammatory disease mediated by cytokines. Nephrol Dial Transplant 1997; 12: 430-437. (Pubitemid 27105614)
25. Taal MW, Zandi-Nejad K, Weening B et al. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 2000; 58: 1664-1676.
26. Junaid A, Rosenberg ME, Hostetter TH. Interaction of angiotensin II and TGF-beta 1 in the rat remnant kidney. J Am Soc Nephrol 1997; 8: 1732-1738. (Pubitemid 27475874)
27. Kobayashi M, Sugiyama H, Wang DH et al. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int 2005; 68: 1018-1031. (Pubitemid 43246418)
28. Cunningham PN, Dyanov HM, Park P et al. Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002; 168: 5817-5823. (Pubitemid 34556169)
29. Gong R, Rifai A, Ge Y et al. Hepatocyte growth factor suppresses proinflammatory NFkappaB activation through GSK3beta inactivation in renal tubular epithelial cells. J Biol Chem 2008; 283: 7401-7410.
30. Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int 1984; 26: 137-143. (Pubitemid 14017051)
31. Miyazaki T, Aoyama I, Ise M et al. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrol Dial Transplant 2000; 15: 1773-1781.
32. Ots M, Mackenzie HS, Troy JL et al. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol 1998; 9: 224-230. (Pubitemid 28092070)
33. Feng Z, Plati AR, Cheng QL et al. Glomerular aging in females is a multistage reversible process mediated by phenotypic changes in progenitors. Am J Pathol 2005; 167: 355-363. (Pubitemid 43026093)
34. Taal MW, Chertow GM, Rennke HG et al. Mechanisms underlying renoprotection during renin-angiotensin system blockade. Am J Physiol Renal Physiol 2001; 280: F343-F355.
35. Taal MW, Zandi-Nejad K, Weening B et al. Proinflammatory gene expression and macrophage recruitment in the rat remnant kidney. Kidney Int 2000; 58: 1664-1676.
36. Peng F, Zhang B, Wu D et al. TGFbeta-induced RhoA activation and fibronectin production in mesangial cells require caveolae. Am J Physiol Renal Physiol 2008; 295: F153-F164.
37. Beg AA, Sha WC, Bronson RT et al. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995; 376: 167-170.